NHS England Expands Pharmacy First Service to Treat Five Additional Health Conditions

Since launching in February 2024, Pharmacy First has delivered 14 million consultations across its original seven conditions, including about 2 million for acute sore throats and more than 1.7 million for urinary tract infections.
The expanded service will initially be offered by only a few hundred pharmacies, with a phased rollout to thousands of participating NHS community pharmacies across England.
The new prescribing categories are more specifically defined as low-frequency episodic migraine in adults, seasonal allergic rhinitis in children, acute otitis externa in adults, mild-to-moderate acne in young people and adults, and mild skin and soft-tissue infections and scabies.
The expansion coincides with the arrival of the first cohort of pharmacists automatically graduating with independent prescribing qualifications; pharmacies employing such pharmacists must apply to become designated “prescribing pharmacies.”
NHS figures cited in the coverage show the scale of related hospital demand in 2024/25: more than 77,000 admissions for ear diseases, 47,500 linked to migraines, 5,000 linked to vasomotor and allergic rhinitis, and 681 for scabies.
NHS England will expand its Pharmacy First service this autumn, letting community pharmacies treat five new conditions without a GP visit: migraines, acne, scabies, ear infections, and allergic rhinitis. Healthcare Management UK reports the rollout will start at a limited number of pharmacies before expanding nationwide. The service already handles seven conditions and has delivered 14 million consultations since launching in February 2024.
NHS England expects the expanded Pharmacy First to generate 2 million to 3 million additional consultations annually, easing pressure on GP practices and emergency departments during winter. Medscape notes this phased expansion marks a major shift in how routine care reaches patients. Pharmacy groups welcomed the move but stressed that pharmacies need sustained financial support to make it work.
Since February 2024, Pharmacy First covered seven conditions: sore throats, sinusitis, shingles, impetigo, infected insect bites, some ear infections, and urinary tract infections. Community Pharmacy England confirms the service delivered 14 million consultations in its first year. Acute sore throats alone accounted for roughly 2 million visits, while urinary tract infections topped 1.7 million.
The new prescribing categories are narrowly defined: low-frequency episodic migraine in adults, seasonal allergic rhinitis in children, acute ear infections in adults, mild-to-moderate acne in young people and adults, and mild scabies and skin infections. Pharmaceutical Journal explains these conditions will join the existing seven-condition list. The service will initially roll out to a few hundred pharmacies before expanding to thousands of NHS community pharmacies across England.
NHS data for 2024/25 reveals the scale of related hospital admissions: more than 77,000 for ear diseases, 47,500 for migraines, 5,000 for allergic rhinitis, and 681 for scabies. Radio News Hub notes these numbers underscore why shifting routine treatment to pharmacies could reduce emergency department strain. Pharmacies equipped with independent prescribing pharmacists will handle most of the expanded caseload.
The expansion coincides with the first cohort of pharmacists graduating with independent prescribing qualifications. Pharmaceutical Journal reports that pharmacies employing these newly qualified prescribers must apply to become designated "prescribing pharmacies" to offer the five new conditions. This ensures consistent training and patient safety across participating locations.
Publishers
16
Articles
4
Reach
20